Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | Video Game Development | Contact

Biotechnology Animations – Biotechnology Illustrations

Clinical Animations / Trial Animations

Clinical Studies Animated Method of Action Video

Medical Animation Studio produces clinical animations and clinical illustrations.  Custom 3d trail illustrations and clinical illustrations for e learning can also be produced.   Biotechnology animations and biotechnology illustrations created for biotech companies and biotechnology marketing companies.
Biotechnology animated method of action video. 
Dr Nano
FDA approve first US vaccine for meningococcal disease serogroup B
Previously, only four of the five main meningococcal disease subgroups have been covered by vaccines in the US. Now, the FDA have approved a vaccine for the fifth - subgroup B.
International study shows improved outcomes for psoriasis patients
Interim results from one of the largest and longest clinical trials ever conducted for a topical treatment in psoriasis showed that after eight weeks of treatment with calcipotriol/betamethasone...
EndoGastric solutions reports two-year durability data from TIF Registry for GERD patients choosing Transoral Incisionless Fundoplication
EndoGastric Solutions® (EGS) has announced publication of US registry data showing that long-term gastroesophageal reflux disease (GERD) sufferers who underwent an incisionless procedure...
Scripps Research Institute MS drug candidate also shows promise for ulcerative colitis
Positive new clinical data has been released on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute (TSRI).
New study correlates use of EXPAREL for postsurgical pain management with significant reductions in opioid related adverse events
Pacira Pharmaceuticals, Inc. has announced results of an independent, physician-initiated study that reinforce the positive impact of an EXPAREL-based pain management regimen on reducing...
UK doctors trial new two-part diabetes screening test
Researchers in Southampton are trialling a new two-part test that could lead to the development of a national screening programme for diabetes.
Rapid and adequate funding of trials on experimental vaccines and therapies needed to address the Ebola epidemic
Not everyone who contracts the Ebola virus dies, the survival rate is around 30% suggesting that some kind of immunity to the disease is possible.
Presented data show palonosetron is a valuable option for treating pediatric patients receiving moderately to highly emetogenic chemotherapy
Helsinn Group, presented data at the International Society of Paediatric Oncology (SIOP) congress establishing that palonosetron, at a dose 20 mug/kg, is a valuable and efficacious treatment option...
Ebola survivors' blood to undergo evaluation as treatment option
An EU-funded project to evaluate the safety and effectiveness of treatment with blood and plasma made from the blood of recovered Ebola patients is due to start soon in Guinea.
Long-term safety and efficacy of once-daily Zonegran® (zonisamide) monotherapy demonstrated in extension of pivotal study
Zonegran® (zonisamide) continues to be well-tolerated and efficacious when used as long-term montherapy for the treatment of partial onset seizures in adults with newly diagnosed epilepsy, as...
Were clinical trial practices in East Germany questionable?
Clinical trials carried out in the former East Germany in the second half of the 20th century were not always with the full knowledge or understanding of participants with some questionable...
Salix's TARGET 3 study examines the safety and efficacy of repeat treatment with Rifaximin for IBS with diarrhea
Salix Pharmaceuticals, Ltd. has announced that Dr. Anthony Lembo of Beth Israel Deaconess Medical Center will present the results of TARGET 3 in a late-breaking podium presentation at the American...
Exalenz Bioscience launches pivotal study of world's first breath-based test to diagnose clinically significant portal hypertension
Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, announced the start of a pivotal...
Schizophrenia: data supporting the efficacy, safety and tolerability of once-daily Latuda® (lurasidone) presented at ECNP 2014
Takeda Pharmaceuticals International GmbH and Sunovion Pharmaceuticals Inc. presented new evidence supporting the use of Latuda® (lurasidone), an atypical antipsychotic treatment for adults...
Clinical trial demonstrates prolonged survival for advanced multiple myeloma patients
John Theurer Cancer Center at Hackensack University Medical Center has announced publication of breakthrough data in the treatment of advanced multiple myeloma in the journal Biology of Blood and...
WindowsFlashQuicktime
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2014
Content Management / Website Design by Tresware